JSM 2013 Home
Online Program Home
My Program

Legend: Palais des congrès de Montréal = CC, Le Westin Montréal = W, Intercontinental Montréal = I
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.

Activity Details

228 * Mon, 8/5/2013, 2:00 PM - 3:50 PM CC-516c
Future Evolution of Data Monitoring Committees — Topic Contributed Papers
Biopharmaceutical Section , Biometrics Section
Organizer(s): Zoran Antonijevic, Cytel
Chair(s): Christy J. Chuang-Stein, Pfizer
2:05 PM The Role of the Data-Monitoring Committee: The Past and the Present in Preparation for the Future John Loewy, Dataforethought
2:25 PM General Considerations for Data Monitoring of Adaptive Trials Zoran Antonijevic, Cytel
2:45 PM Communication, Confidentiality, and Oversight Issues for DMCs in Adaptive Trials Paul Gallo, Novartis
3:05 PM Discussant: Matilde Sanchez, Arena Pharmaceuticals; Inc
3:25 PM Discussant: Kerry Barker, Pfizer Inc.
3:45 PM Floor Discussion

2013 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

ASA Meetings Department  •  732 North Washington Street, Alexandria, VA 22314  •  (703) 684-1221  •  meetings@amstat.org
Copyright © American Statistical Association.